Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Date: September 30, 2012
Pages: 95
Price:
US$ 3,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A533F3B036EEN
Leaflet:

Download PDF Leaflet

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, “Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides key market data on the Asia-Pacific Diabetes Care Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Countries covered include Australia, China, India and Japan.
  • Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories and countries.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices market..
  • Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Novo Nordisk A/S, Arkray, Inc., Eli Lilly and Company, Abbott Laboratories and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 DIABETES CARE DEVICES IN ASIA-PACIFIC

3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
3.2 Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Diabetes Care Devices, Asia-Pacific, Company share (2010-2011)

4 DIABETES CARE DEVICES IN JAPAN

4.1 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Diabetes Care Devices, Japan, Distribution Share (2010-2011)
  4.2.1 Glucose Monitoring, Japan, Distribution Share (2010-2011)
  4.2.2 Insulin Delivery, Japan, Distribution Share (2010-2011)
4.3 Diabetes Care Devices, Japan, Company Share (2010-2011)
  4.3.1 Diabetes Care Devices, Japan, Company Share (2010-2011)
  4.3.2 Glucose Monitoring, Japan, Company Share (2010-2011)
  4.3.3 Insulin Delivery, Japan, Company Share (2010-2011)

5 DIABETES CARE DEVICES IN AUSTRALIA

5.1 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Diabetes Care Devices, Australia, Distribution Share (2010-2011)
  5.2.1 Glucose Monitoring, Australia, Distribution Share (2010-2011)
  5.2.2 Insulin Delivery, Australia, Distribution Share (2010-2011)
5.3 Diabetes Care Devices, Australia, Company Share (2010-2011)
  5.3.1 Diabetes Care Devices, Australia, Company Share (2010-2011)
  5.3.2 Glucose Monitoring, Australia, Company Share (2010-2011)
  5.3.3 Insulin Delivery, Australia, Company Share (2010-2011)

6 DIABETES CARE DEVICES IN CHINA

6.1 Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018
6.2 Diabetes Care Devices, China, Distribution Share (2010-2011)
  6.2.1 Glucose Monitoring, China, Distribution Share (2010-2011)
  6.2.2 Insulin Delivery, China, Distribution Share (2010-2011)
6.3 Diabetes Care Devices, China, Company Share (2010-2011)
  6.3.1 Diabetes Care Devices, China, Company Share (2010-2011)
  6.3.2 Glucose Monitoring, China, Company Share (2010-2011)
  6.3.3 Insulin Delivery, China, Company Share (2010-2011)

7 DIABETES CARE DEVICES IN INDIA

7.1 Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018
7.2 Diabetes Care Devices, India, Distribution Share (2010-2011)
  7.2.1 Glucose Monitoring, India, Distribution Share (2010-2011)
  7.2.2 Insulin Delivery, India, Distribution Share (2010-2011)
7.3 Diabetes Care Devices, India, Company Share (2010-2011)
  7.3.1 Diabetes Care Devices, India, Company Share (2010-2011)
  7.3.2 Glucose Monitoring, India, Company Share (2010-2011)
  7.3.3 Insulin Delivery, India, Company Share (2010-2011)

8 OVERVIEW OF KEY COMPANIES IN ASIA-PACIFIC DIABETES CARE DEVICES MARKET

8.1 F. Hoffmann-La Roche Ltd.
  8.1.1 Company Overview
  8.1.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.2 LifeScan, Inc.
  8.2.1 Company Overview
  8.2.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.3 Novo Nordisk A/S
  8.3.1 Company Overview
  8.3.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.4 ARKRAY, Inc.
  8.4.1 Company Overview
  8.4.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.5 Eli Lilly and Company
  8.5.1 Company Overview
  8.5.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.6 Abbott Laboratories
  8.6.1 Company Overview
  8.6.2 Share in the Asia-Pacific Diabetes Care Devices Market
8.7 Sanofi
  8.7.1 Company Overview
8.8 Medtronic, Inc.
  8.8.1 Company Overview
8.9 Bayer HealthCare AG
  8.9.1 Company Overview
8.10 Terumo Corporation
  8.10.1 Company Overview
8.11 Becton, Dickinson and Company
  8.11.1 Company Overview
8.12 Nipro Corporation
  8.12.1 Company Overview
8.13 Hindustan Syringes & Medical Devices Ltd.
  8.13.1 Company Overview
8.14 Animas Corporation
  8.14.1 Company Overview
8.15 B. Braun Melsungen AG
  8.15.1 Company Overview

9 DIABETES CARE DEVICES MARKET PIPELINE PRODUCTS

10 FINANCIAL DEALS LANDSCAPE

10.1 Partnerships
  10.1.1 Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare
  10.1.2 Insulet Expands Distribution Agreement With Ypsomed Holding

11 RECENT DEVELOPMENTS

11.1 Strategy And Business Planning
  11.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center
  11.1.2 Aug 09, 2012: Takeda Establishes Development Center In China
  11.1.3 Apr 06, 2012: Biocon Opens New INR2 Billion Biologics Research Facility In Bangalore, India
  11.1.4 Mar 27, 2012: Terumo Establishes New Holding Company In Singapore
  11.1.5 Nov 04, 2011: Takeda Announces New Structure Of Business Operations
11.2 Research And Development
  11.2.1 Jul 17, 2012: Greatbatch To Establish R&D Centre In Singapore
  11.2.2 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research
  11.2.3 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug Discovery Partnership
11.3 Legal and Regulatory
  11.3.1 Aug 01, 2012: Terumo Files Lawsuit For Compensation Of Damages Against Olympus
  11.3.2 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision
  11.3.3 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In Dispute With Takeda
  11.3.4 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For Medical Devices

12 APPENDIX

12.1 Definitions of Markets Covered in the Report
  12.1.1 Diabetes Care Devices
12.2 Research Methodology
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panels
12.8 GlobalData Consulting
12.9 Currency Conversion
12.10 Contact Us
12.11 Disclaimer

LIST OF TABLES

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 5: Diabetes Care Devices, Asia-Pacific, Company share by Revenue ($m), USD Constant, 2010-2011
Table 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018
Table 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 9: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 10: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Glucose Monitoring, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018
Table 15: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 16: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 17: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Diabetes Care Devices, Australia, Company Share, USD Constant, (2010-2011)
Table 20: Glucose Monitoring, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Insulin Delivery, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018
Table 23: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 24: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 25: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 26: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 27: Diabetes Care Devices, China, Company Share, USD Constant, (2010-2011)
Table 28: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Insulin Delivery, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018
Table 31: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 32: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 33: Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Insulin Delivery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Diabetes Care Devices, India, Company Share, USD Constant, (2010-2011)
Table 36: Glucose Monitoring, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Insulin Delivery, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Diabetes Care Devices Market Pipeline Products
Table 39: Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare
Table 40: Insulet Expands Distribution Agreement With Ypsomed Holding

LIST OF FIGURES

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 5: Diabetes Care Devices, Asia-Pacific, Company share (%), 2011
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 9: Diabetes Care Devices, Japan, Company Share (%), 2011
Figure 10: Glucose Monitoring, Japan, Company Share (%), 2011
Figure 11: Insulin Delivery, Japan, Company Share (%), 2011
Figure 12: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018
Figure 13: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 15: Diabetes Care Devices, Australia, Company Share (%), 2011
Figure 16: Glucose Monitoring, Australia, Company Share (%), 2011
Figure 17: Insulin Delivery, Australia, Company Share (%), 2011
Figure 18: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018
Figure 19: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 20: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 21: Diabetes Care Devices, China, Company Share (%), 2011
Figure 22: Glucose Monitoring, China, Company Share (%), 2011
Figure 23: Insulin Delivery, China, Company Share (%), 2011
Figure 24: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018
Figure 25: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 26: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 27: Diabetes Care Devices, India, Company Share (%), 2011
Figure 28: Glucose Monitoring, India, Company Share (%), 2011
Figure 29: Insulin Delivery, India, Company Share (%), 2011
Figure 30: F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
Figure 31: LifeScan, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
Figure 32: Novo Nordisk A/S, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
Figure 33: ARKRAY, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
Figure 34: Eli Lilly and Company, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
Figure 35: Abbott Laboratories, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Novo Nordisk A/S
ARKRAY, Inc.
Eli Lilly and Company
Abbott Laboratories
Sanofi
Medtronic, Inc.
Bayer HealthCare AG
Terumo Corporation
Becton, Dickinson and Company
Nipro Corporation
Hindustan Syringes & Medical Devices Ltd.
Animas Corporation
B. Braun Melsungen AG

Ask Your Question

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: